Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

13.47
-0.1100-0.81%
Volume:912.00K
Turnover:12.26M
Market Cap:2.18B
PE:611.21
High:13.62
Open:13.62
Low:13.18
Close:13.58
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.54
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:9.05
PE(LYR):303.41

Loading ...

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Vertex 1Q Net Y772.00m vs Net Y658.00m

Dow Jones
·
Aug 12

Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

TIPRANKS
·
Aug 11

Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $556 From $555, Maintains Buy Rating

MT Newswires Live
·
Aug 11

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals Inc. Stock Rises 5.6%, Outperforms Peers

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO), Silence Therapeutics (SLN) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals price target raised to $672 from $605 at BofA

TIPRANKS
·
Aug 11

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Early notable gainers among liquid option names on August 10th

TIPRANKS
·
Aug 10

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

TIPRANKS
·
Aug 06

Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays

TIPRANKS
·
Aug 05

Vertex Inc. Earnings Call Shows Profitable Growth

TIPRANKS
·
Aug 05

Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says

MT Newswires Live
·
Aug 05

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live
·
Aug 05